Safety of Birth Control and Contraception: Pharmaceutical
Companies on the Testing Bench
Volume 1 - Issue 4
Kurt Kraetschmer MD, PhD*
-
Author Information
Open or Close
- Department of Pharmacology, Austrian-American Medical Research Institute
*Corresponding author:
Kurt Kraetschmer, Department of Pharmacology, Austrian-American Medical Research Institute
Received:June 27, 2019 Published:July 03, 2019
DOI: 10.32474/LOJPCR.2019.01.000116
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Aim: On the background of reports concerning harm to the health of users of a contraceptive product, the paper aims at
emphasizing the manufacturers’ responsibility to warrant safe use of contraceptive pills and devices.
Method: The method consists in an analysis of sources of information commonly used by women and their healthcare providers,
ie, “information for use“ provided by manufacturers and statements by renowned agencies, such as WHO, FDA, National Center for
Health Research, and CDC. Also, research publications in scholarly journals are critically analysed.
Results: Presently, women do not receive information necessary for the safe use of contraceptive pills and devices -- neither
from all pharmaceutical companies nor from healthcare providers.
Conclusion: Comprehensive, complete, and reliable information on all available methods of contraception is difficult to obtain.
Pharmaceutical companies should be obliged by law to inform the users of their products in a comprehensible manner about all
risks and potential complications without using a confusing, deceptive, or misleading vocabulary.
Materials|
Methods|
Findings|
Discussion|
The Manufacturer’s Description of the Implant for
Sterilization and INSTRUCTIONS for Use|
Deficits in the Information for Use Provided by the
Manufacturer|
An Implant in Disguise of an Insert|
Women in Search of “Safe” Methods of Birth
Control and Contraception|
Conclusion and Implications|
References|